Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Innoviva Inc. (INVA)

14.54   0.04 (0.28%) 05-22 16:00
Open: 14.45 Pre. Close: 14.5
High: 14.725 Low: 14.34
Volume: 659,596 Market Cap: 1472M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.744 - 14.8 14.8 - 14.866
Low: 14.186 - 14.247 14.247 - 14.317
Close: 14.427 - 14.524 14.524 - 14.637

Technical analysis

as of: 2019-05-22 4:24:53 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 17.84     One year: 20.83
Support: Support1: 13.91    Support2: 13.07
Resistance: Resistance1: 15.27    Resistance2: 17.84
Pivot: 14.63
Moving Average: MA(5): 14.53     MA(20): 14.43
MA(100): 15.47     MA(250): 15.27
MACD: MACD(12,26): 0.11     Signal(9): 0.12
Stochastic oscillator: %K(14,3): 47.00     %D(3): 50.28
RSI: RSI(14): 52.78
52-week: High: 20.54  Low: 13.07  Change(%): 3.1
Average Vol(K): 3-Month: 93634  10-Days: 135091

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
INVA has closed above bottom band by 39.4%. Bollinger Bands are 66% narrower than normal. The narrow width of the bands suggests low volatility as compared to INVA's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 22 May 2019 13:10:41 Z
5 Biotech Stocks to Gain From Trade Deal Rally on the Horizon

Wed, 15 May 2019 16:13:30 Z
New Strong Buy Stocks for May 15th

Wed, 15 May 2019 16:11:52 Z
Earnings Estimates Moving Higher for Innoviva (INVA): Time to Buy?

Fri, 26 Apr 2019 17:10:16 Z
Commit To Buy Innoviva At $10, Earn 9.9% Annualized Using Options

Thu, 18 Apr 2019 17:08:46 Z
Innoviva Becomes Oversold (INVA)

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 101.26
Shares Float (M) 94.31
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 3.590
EPS Est. Current Year 1.130
EPS Est. Next Year 1.930
EPS Est. Next Quarter 0.480
Forward EPS 2.190
Book Value (p.s.) 7.970
PEG Ratio 0.49
Profit Margin
Operating Margin 94.96
Return on Assets (ttm) 94.8
Return on Equity (ttm) -12715.0
Qtrly Rev. Growth 5.4
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 14.20
Operating Cash Flow (M) 250.27
Levered Free Cash Flow (M) 163.54

Stock Valuations

P/E 4.05
P/E Growth Ratio
P/BV 1.82
P/S 564107392.00
P/CF 5.88

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date 2015-09-30
Ex-Dividend Date 2015-09-08
Forward Dividend
Last Split Date 2014-06-03
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.